You have 9 free searches left this month | to do more

Spartalizumab

Spartalizumab is a drug used to treat Head and Neck Squamous Cell Carcinoma, Melanoma, Carcinoma, Non-Small-Cell Lung, and other conditions. Spartalizumab is being actively studied in 13 studies and prior, has been studied in 3.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative SiteMatthew Dallos
Assistance Publique - Hopitaux de ParisMassachusetts General Hospital Massachusetts General Hospital
M.D. Anderson Cancer CenterHighlands Oncology Group
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Not yet recruiting
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • (no location specified)
2021-11-15
Nov 15, 2021
N
Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-02-24
Feb 24, 2021
N
Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fayetteville, Arkansas
  • +7 more
2022-01-21
Jan 21, 2022
M
Recruiting
  • Carcinoma, Renal Cell
  • New York, New York
    Columbia University Medical Center
2021-01-12
Jan 12, 2021
N
Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +8 more
2022-03-18
Mar 18, 2022
M
Active, not recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-28
Jun 28, 2021
N
Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Spartalizumab
  • +2 more
  • Boston, Massachusetts
  • +15 more
2022-03-31
Mar 31, 2022
S
Recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Spartalizumab
  • Badalona, Barcelona, Spain
  • +9 more
2021-08-13
Aug 13, 2021
N
Active, not recruiting
  • Melanoma
  • Spartalizumab
  • +4 more
  • Los Angeles, California
  • +30 more
2022-03-14
Mar 14, 2022
N
Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
2021-03-02
Mar 2, 2021
N
Active, not recruiting
  • Triple Negative Breast Cancer (TNBC)
  • spartalizumab
  • +5 more
  • Boston, Massachusetts
  • +13 more
2022-01-26
Jan 26, 2022
N
Completed
  • Nasopharyngeal Carcinoma
  • Spartalizumab
  • Investigator choice of chemotherapy
  • Marietta, Georgia
  • +17 more
2022-01-17
Jan 17, 2022
N
Recruiting
  • BRAF V600 Colorectal Cancer
  • Los Angeles, California
  • +17 more
2022-01-12
Jan 12, 2022
N
Active, not recruiting
  • Melanoma
  • Spartalizumab
  • +3 more
  • Orange, California
  • +178 more
2022-03-02
Mar 2, 2022